Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Top Life Sciences Consultancies in the USA: How EvoLV Stands Out

Apr 22, 2025

The Role of Life Sciences Consultancies

The life sciences sector is an ever-evolving landscape, requiring innovative solutions and expertise to address the complexities of modern healthcare challenges. Life sciences consultancies play a pivotal role in guiding companies through regulatory hurdles, research and development processes, and market strategies. In the USA, several top-tier consultancies are known for their exceptional service and industry knowledge.

These firms provide a wide range of services, from clinical trials management to regulatory compliance and market access strategies. They act as strategic partners, enabling life sciences companies to focus on their core competencies while navigating the intricate pathways of the healthcare industry.

life sciences consultancy

EvoLV: A Leader in Life Sciences Consulting

Among these elite consultancies, EvoLV stands out for its comprehensive approach and deep industry insights. Founded by industry veterans, EvoLV has quickly ascended the ranks by offering tailored solutions that address the unique needs of each client. Their team of experts brings a wealth of experience in pharmaceuticals, biotechnology, and medical devices.

EvoLV's commitment to innovation is evident in their ability to adapt to the rapidly changing landscape of life sciences. By leveraging cutting-edge technologies and methodologies, they ensure that their clients remain at the forefront of the industry.

Services Offered by EvoLV

EvoLV's service offerings are diverse and designed to meet the varied needs of life sciences companies. Some of their key services include:

  • Regulatory Consulting: Assisting clients with navigating complex regulatory environments.
  • Clinical Development: Providing support through all phases of clinical trials.
  • Market Access: Crafting strategies for successful product launches and market penetration.
  • Strategic Planning: Offering insights for long-term growth and sustainability.
business team meeting

EvoLV's Unique Approach

What sets EvoLV apart is their client-centric approach. They prioritize understanding the specific challenges and objectives of each client, ensuring that their solutions are not only effective but also sustainable. EvoLV fosters strong partnerships with their clients, working collaboratively to achieve shared goals.

Their emphasis on continuous improvement and feedback loops allows them to refine their strategies and deliver optimal results. This dedication to excellence has earned EvoLV a reputation as a trusted advisor in the life sciences community.

The Impact of EvoLV's Work

EvoLV's impact on the life sciences sector is significant. By helping companies streamline operations, reduce time-to-market, and maintain compliance, they contribute to the overall advancement of healthcare innovations. Their work not only benefits individual companies but also enhances the broader healthcare ecosystem by facilitating access to new and effective treatments.

healthcare innovation

Conclusion

In a competitive market, standing out requires a blend of expertise, innovation, and adaptability—qualities that EvoLV embodies in its consultancy services. For life sciences companies seeking a partner who can provide strategic insights and drive success, EvoLV offers a distinctive edge.

As the life sciences sector continues to grow and evolve, having a consultancy like EvoLV by your side can make all the difference in achieving both immediate objectives and long-term success. Their commitment to excellence ensures that clients are well-equipped to navigate the complexities of the industry with confidence.